In the APP23 transgenic mouse model of AD, suppression of the TNF-α receptor 1 diminished Aβ production and plaque formation by reducing BACE1 activity, which, in parallel, reduced disease-associated cognitive dysfunctions (He et al., 2007). The gene discussed is BACE1; the disease is Alzheimer disease.